Company / Income Tax
AMICUS THERAPEUTICS, INC. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$27.3M
FY2025
5-year range
-$5.5M / $27.4M
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
#35 of 204
Health Care
What the data says
AMICUS THERAPEUTICS, INC.'s income tax of $27M is higher than 83% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$165M in FY2017 to $27M in FY2024.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of +60.1%. Top quartile in the Health Care sector.
Increased from $1M to $27M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +60.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 204This company $27.3M Sector average $118.7M
▼
-77.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +60.1%, indicating consistent growth.
- In FY2025, income tax decreased 0.2% year-over-year.
- Ranks #35 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.3M | -0.2% |
| FY2024 | $27.4M | +1744.2% |
| FY2023 | $1.5M | +127.1% |
| FY2022 | -$5.5M | -161.4% |
| FY2021 | $8.9M | +242.8% |
| FY2020 | $2.6M | +443.5% |
| FY2019 | $478.0K | +608.5% |
| FY2018 | -$94.0K | +99.9% |
| FY2017 | -$165.1M | -4316.1% |
| FY2016 | -$3.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026